Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
COMPANY
Canaccord Genuity
External broker reports(aggregated public sources)
Follow
Location:
Canada
34
Insights
10.0k
Views
3
Followers
Australia
•
Equity Bottom-Up
Follow
Regions
Sectors
Verticals
More Filters
Refresh
Top Picks Only
Recent
bullish
•
PYC Therapeutics
•
17 Aug 2024 04:20
•
Broker
PYC Therapeutics Limited - Flash Update
VP-001 received the most attention in the presentation and discussions, given recent positive updates showing improved visual function in the...
Canaccord Genuity
Follow
299 Views
Share
bullish
•
PYC Therapeutics
•
12 Aug 2024 21:22
•
Broker
PYC Therapeutics Limited - 2Q24: In Line, All Eyes on RP11 Data and ADPKD Trial Timing
PYC reported its 2Q24 result, in line with expectations around R&D spend and progress with clinical and preclinical assets.
Canaccord Genuity
Follow
120 Views
Share
bullish
•
PYC Therapeutics
•
12 Aug 2024 21:19
•
Broker
PYC Therapeutics Limited - Ticking the Boxes with Two Patients at Four Months with VP-001
PYC has announced follow-up data from the second patient in its Phase 1/2 study assessing VP-001 for Retinitis Pigmentosa 11 (RP11), a rare...
Canaccord Genuity
Follow
113 Views
Share
bullish
•
Bannerman Resources
•
12 Aug 2024 21:16
•
Broker
Bannerman Energy Ltd - JunQ'24 - Strategic Funding in Focus
BMN completed its Front-End Engineering and Design (FEED) and Control Budget Estimate (CBE) for the 3.5Mlb/y Etango-8 development in June.
Canaccord Genuity
Follow
120 Views
Share
bullish
•
PYC Therapeutics
•
01 Jul 2024 07:59
•
Broker
PYC Therapeutics Limited - Making Sense of the PPMO-CPP Combination
Initiating on PYC Therapeutics with a BUY rating and risked price target of $0.22. PYC is a clinical stage biotechnology company in the gene...
Canaccord Genuity
Follow
214 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x